"Designing Growth Strategies is in our DNA"

Molecular Diagnostics Market Size, Share and Industry Analysis By Product Type (Instruments Reagents & Consumables), By Application (Infectious Disease, Blood Screening, Histology & Oncology), By Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs), and Regional Forecast 2018-2025

Region : Global | Format: PDF | Report ID: FBI100086

 

KEY MARKET INSIGHTS

Play Audio Listen to Audio Version

The Global Molecular Diagnostics Market size was valued at USD 8.01 Billion in 2017 and is projected to reach USD 13.87 Billion by 2025, exhibiting a CAGR of 7.1% during the forecast period (2018-2025).  During the last decade, molecular diagnostics has emerged as a superior methodology and achieved the goal of faster disease diagnosis along with minimal complexities. The demand for these procedures is higher, particularly for the diagnosis of infectious diseases.


The growing prevalence of infectious diseases in both developing and developed nations is boosting the demand for molecular diagnosis. Major viral and bacterial outbreaks in the Middle East & Africa forced all governments and research institutions across the globe to adopt molecular diagnostic techniques to inhibit the microbial outbreaks. In terms of techniques, the amplification techniques segment is projected to hold considerable share in the global market. Consumables and reagent segments are also expected to hold considerable share in this market.


Request a Free sample to learn more about this report.


Key Market Drivers


Infectious Diseases are expected to drive the molecular diagnostics market growth


Currently, managing the microbial outbreaks and infections across the globe is a big challenge faced by all the governments worldwide. Huge amount of resource engagement in terms of technology, expertise and finance serves, and favorable environment for the imitation of research projects, particularly for infectious diseases is boosting the market for molecular diagnostics. The Infectious diseases application segment accounted for a market share of 60.0 % in 2017. Moreover, rise in awareness programs initiated by global organizations such as World Health Organization (WHO), World Bank and others for infectious diseases are expected to encourage the talent pool to step forward with the aim to achieve higher utilization of such diagnostic technologies.


Market Segmentation


To know how our report can help streamline your business, Speak to Analyst


Based on applications, the global molecular diagnostic market segments includes infectious diseases, blood screening, histology, oncoloogy, and others. Infectious diseases held an estimated 60.0% of the market share in 2017. Based on the product type, the global molecular diagnostic market includes reagents and consumable. In terms of techniques, the global molecular diagnostic market is categorized as hospitals amplification techniques, hybridization techniques, sequencing techniques, and others.


Various end users in the global market are clinical & pathology labs, hospitals, and others (physicians’ offices, clinics, emergency centers, long-term & urgent care centers, etc). Lucrative reimbursement strategies offered by the government for the implementation of molecular diagnostics signifies considerable growth in the execution of these diagnosis systems in clinical & pathology labs as well as in hospitals.


Regional Analysis


Reinforcement Strategies of Government Institutions for Molecular Diagnostics Reflected as Higher Growth of the Market in North America


North America Molecular Diagnostics Market Size, 2017

To get more information on the regional analysis of this market, Request a Free sample


North America generated revenue of USD 3.64 Bn in 2017, and is anticipated to emerge dominant in the molecular diagnostics market share during the forecast period. Growth witnessed in the region is likely to be driven by the increasing association and collaborative efforts taken by both large academic institutions and research hospitals. Moreover, the increasing interactions between hospital research organizations and academic institutions for process improvements will help boost the market. The utilization of large amount of molecular diagnostics for improvisation of clinical efficiency are projected to offer significant growth for the molecular diagnostic market during the forecast period.


Moreover, the rising emphasis of bigger hospital research and clinical microbiology organizations, and their collective efforts to increase the level of molecular diagnostics are expected to drive the market in Europe. Though, improvements in Asia Pacific and Latin America are currently in premature stage, rapidly developing infrastructure and increasing investments in research and development are anticipated to serve huge potentials for the growth of the market in Asia Pacific.


Key Market Players


QIAGEN, F. Hoffmann-La Roche Ltd., Danaher Corporation, and Abbott Laboratories Expected to Hold Considerable Share in the Global Market


Giant organizations such as QIAGEN, F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories are expected to lead the global market during the forecast period. Optimal research & development strategies, robust supply chain network, increasing investments in research & development and cost management are projected to serve huge opportunity for the aforementioned market players to lead this market during the forecast period. Moreover, higher potential for intense penetration of advanced diagnostics in the Asia Pacific market may offer significant share for the companies in terms of revenue in the global molecular diagnostics market.


Molecular Diagnostic Market Players



  • bioMérieux SA.

  • BD

  • Danaher Corporation

  • Grifols, S.A.

  • Hologic Inc.

  • Novartis AG

  • QIAGEN

  • Siemens Healthcare GmbH

  • F. Hoffmann-La Roche Ltd.

  • Other players


KEY INDUSTRY DEVELOPMENTS:



  • March 2021 – Roche and GenMark Diagnostics entered into a merger agreement for Roche to acquire GenMark completely. By acquiring the company, GenMark’s syndromic panel testing portfolio will supplement the Roche’s current molecular diagnostics portfolio.

  • March 2021 - QIAGEN N.V. made an announcement of the launch of the QIAcube Connect MDx, an adaptable platform for automated sample processing to be available to molecular diagnostic laboratories in the U.S. and Canada and other markets globally.

  • April 2020 – BD, a medical technology company, and BioGX Inc., a molecular diagnostics company, made an announcement of submitting the Emergency Use Authorization requests for the approval of new diagnostic test to U.S. Food and Drug Administration (FDA) which when approved will allow hospitals to screen for COVID-19 and get the results in three hours.


Report Coverage 


The science of medical diagnostics is witnessing remarkable achievements in terms of new diagnostic domains and philosophies. The popularity of molecular diagnostics is continuously increasing in life sciences due to its extensive applications, promising solutions, and methodologies for disease diagnosis on molecular level.


The molecular diagnostics market report provides both qualitative and quantitative insights on molecular diagnostics industry trends and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented into product type, application, technique, and end user. On the basis of product type, the global market is categorized into instruments and reagents & consumables.


Based on applications, the market is segmented into infectious disease, blood screening, histology, oncology, and others. Based on techniques, this market is segmented into amplification techniques, hybridization techniques, sequencing techniques, and others. Various end users covered in the report are clinical and pathology laboratories, hospitals, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. These regions are further categorized into countries.


An Infographic Representation of Molecular Diagnostics Market

To get information on various segments, share your queries with us



Along with this, the report analysis includes market dynamics and a competitive landscape. Various key insights provided in the report are Porter’s five forces analysis, recent advancements in molecular diagnostics, key mergers & acquisitions, and others.


Molecular Diagnostic Market Segment






























 ATTRIBUTE


 DETAILS

By Product Type




  • Instruments

  • Reagents & Consumables



By Application




  • Infectious Disease

  • Blood Screening

  • Histology

  • Oncology

  • Others



By Technique




  • Amplification Techniques

  • Hybridization Techniques

  • Sequencing Techniques

  • Others



By End User




  • Hospitals

  • Clinical & Pathology Labs

  • Others



By Geography




  • North America (USA and Canada)

  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

  • Latin America (Brazil, Mexico and Rest of Latin America)

  • Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



Frequently Asked Questions

Based on the detailed study conducted by Fortune Business Insights, the molecular diagnostic market was valued at USD 8.01 Billion in 2017.

Fortune Business Insights has estimated the value of the molecular diagnostic market at USD 13.87 Billion in 2025.

The molecular diagnostic market is projected to grow at a CAGR of 7.1% during the forecast period.

In 2017, North America dominated the molecular diagnostic market by generating a revenue of USD 3.63 Billion.

Increasing prevalence of infectious diseases is driving the growth of global molecular diagnostic market.

BD, Danaher and Grifols, S.A. are the companies that dominated the molecular diagnostic market in 2017

Based on the analysis done by Fortune Business Insights, the molecular diagnostic market is expected to witness significant opportunities owing to the increasing demand of molecular diagnostic in treatment of different infections.

Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts

Speak to an Expert
  • Apr, 2019
  • 2017
  • 2014-2016
  • 155

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $6850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X